<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2954-3835</journal-id>
<journal-title><![CDATA[Cardiovascular and metabolic science]]></journal-title>
<abbrev-journal-title><![CDATA[Cardiovasc. metab. sci]]></abbrev-journal-title>
<issn>2954-3835</issn>
<publisher>
<publisher-name><![CDATA[Asociación Nacional de Cardiólogos de México A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2954-38352023000200045</article-id>
<article-id pub-id-type="doi">10.35366/111546</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Initial results of the National Survey of Cardiovascular Risk Factors in Mexican women: «ENAFARC Mexico»]]></article-title>
<article-title xml:lang="es"><![CDATA[Resultados iniciales de la Encuesta Nacional de Factores de Riesgo Cardiovascular en la mujer mexicana: «ENAFARC México»]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Puente-Barragán]]></surname>
<given-names><![CDATA[Adriana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Madrid-Miller]]></surname>
<given-names><![CDATA[Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nuriulú-Escobar]]></surname>
<given-names><![CDATA[Patricia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García-Jiménez]]></surname>
<given-names><![CDATA[Yoloxochitl]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Anguiano-Torres]]></surname>
<given-names><![CDATA[Germán]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado CMN 20 de Noviembre ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Asociación Nacional de Cardiólogos de México A.C..  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Cardiovascular Prevention Clinic  ]]></institution>
<addr-line><![CDATA[Pachuca Hidalgo]]></addr-line>
<country>México</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,UMAE Hospital de Especialidades No. 14  ]]></institution>
<addr-line><![CDATA[Veracruz ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Cardiometabolic Prevention Center Sagittarius Medical Center ]]></institution>
<addr-line><![CDATA[Zapopan Jalisco]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2023</year>
</pub-date>
<volume>34</volume>
<numero>2</numero>
<fpage>45</fpage>
<lpage>53</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2954-38352023000200045&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2954-38352023000200045&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2954-38352023000200045&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  cardiovascular disease (CVD) continues to be the leading cause of death worldwide in women, associated with different cardiovascular risk factors (CVRF), both traditional, sex-specific and emerging.  Objective:  to know the frequency of traditional and sex-specific CVRF in the Mexican female population based on the National Survey of Cardiovascular Risk Factors (ENAFARC Mexico) results.  Material and methods:  surveys collected by doctors, nutritionists or nursing staff were conducted in 23 cities in Mexico. An individual standardized questionnaire with closed answers, anthropometry and laboratory tests was applied, aimed at women who attended primary care, specialty care and detection campaigns in the open population.  Results:  analysis included 2,304 surveys. The average age was 53.4 to 15.8 years old. Rich carbohydrate and saturated fat diets were reported in 51 to 62%, sedentary lifestyle in 60.5%, obesity in 32.7%, hypertension in 41.2%, dyslipidemia in 34.5%, diabetes in 21.3%, and 51.2% had metabolic syndrome criteria. 54.4% were in the postmenopausal stage; of these, 22.1% with premature menopause and 47% had at least two added risk factors (OR 2.91, 95% CI 2.56-3.31). Hypertensive disorders of pregnancy were significantly associated with the development of chronic hypertension ten years after delivery (OR 2.53 with 95% CI 1.93-3.31).  Conclusions:  there is a high frequency of traditional, sex-specific and emerging CVRF in Mexican women, mainly in postmenopausal. The etiology seems to be multifactorial and importantly related to various sociocultural determinants.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  la enfermedad cardiovascular (ECV) sigue siendo la principal causa de muerte a nivel mundial en las mujeres, asociada a diferentes factores de riesgo cardiovascular (FRCV) tanto los tradicionales como los ligados al sexo y los emergentes.  Objetivo:  conocer la frecuencia de los FRCV tradicionales y sexo-específicos de la población femenina en México, con base en los resultados de la Encuesta Nacional de Factores de Riesgo Cardiovascular (ENAFARC México).  Material y métodos:  se realizaron encuestas recolectadas por médicos, nutriólogos o personal de enfermería, en 23 ciudades de México. Se aplicó un cuestionario individual estandarizado con respuestas cerradas, antropometría y exámenes de laboratorio, dirigidas a mujeres que acudían a consulta de atención primaria, de especialidad y campañas de detección en población abierta.  Resultados:  se incluyeron en el análisis 2,304 encuestas. La edad promedio fue de 53.4 ± 15.8 años. Con alimentación rica en carbohidratos en 62% y grasas saturadas en 51.2%, así como sedentarismo en 60.5%. Cursaban con obesidad 32.7%, 41.2% con hipertensión arterial, 34.5% con dislipidemia, 21.3% con diabetes y 51.2% con síndrome metabólico. Por otro lado, 54.4% estaban en etapa menopáusica, de éstas 22.1% con menopausia prematura y 47% contaban con al menos dos factores de riesgo agregado (OR 2.91, IC 95% 2.56-3.31). Los trastornos hipertensivos del embarazo se asociaron significativamente al desarrollo de hipertensión crónica 10 años después del parto (OR 2.53 con IC 95% 1.93-3.31).  Conclusiones:  existe una elevada frecuencia de FRCV tradicionales, sexo-específicos y emergentes en la mujer mexicana, principalmente durante la menopausia. La etiología parece ser multifactorial e importantemente relacionada a diversos determinantes socioculturales.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[traditional risk factors]]></kwd>
<kwd lng="en"><![CDATA[sex-specific risk factors]]></kwd>
<kwd lng="en"><![CDATA[female cardiovascular disease]]></kwd>
<kwd lng="en"><![CDATA[female risk factors]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo tradicionales]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo sexo-específicos]]></kwd>
<kwd lng="es"><![CDATA[enfermedad cardiovascular en la mujer]]></kwd>
<kwd lng="es"><![CDATA[factores de riesgo de la mujer]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bairey Merz]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Andersen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sprague]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Burns]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Keida]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, attitudes, and beliefs regarding cardiovascular disease in women: the Women&#8217;s Heart Alliance]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2017</year>
<volume>70</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>123-32</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>INEGI</collab>
<source><![CDATA[Características de las defunciones registradas en México. Comunicado de prensa núm. 600/22 del 26 de octubre de 2022]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mosca]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Benjamin]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Berra]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bezanson]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Dolor]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lloyd-Jones]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness-based guidelines for the prevention of cardiovascular disease in women&#8212;2011 update: a guideline from the American Heart Association]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2011</year>
<volume>57</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1404-23</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sciomer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moscucci]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Maffei]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gallina]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mattioli]]></surname>
<given-names><![CDATA[AV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention of cardiovascular risk factors in women: The lifestyle paradox and stereotypes we need to defeat]]></article-title>
<source><![CDATA[Eur J Prev Cardiol]]></source>
<year>2019</year>
<volume>26</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>609-10</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jayasena]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Franks]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The management of patients with polycystic ovary syndrome]]></article-title>
<source><![CDATA[Nat Rev Endocrinol]]></source>
<year>2014</year>
<volume>10</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>624-36</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Elgendy]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Epps]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lindley]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC State-of-the-Art Review]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2020</year>
<volume>75</volume>
<numero>20</numero>
<issue>20</issue>
<page-range>2602-18</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Honigberg]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Zekavat]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Aragam]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Klarin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bhatt]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term cardiovascular risk in women with hypertension during pregnancy]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2019</year>
<volume>74</volume>
<numero>22</numero>
<issue>22</issue>
<page-range>2743-54</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fatima]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Sreekantha]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A comparative study of serum estrogen and lipid profile in premenopausal and post-menopausal women as atherosclerotic risk factors. TC (mg/dl)]]></article-title>
<source><![CDATA[Int J Clin Biochem Res]]></source>
<year>2017</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>237-41</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sueldo]]></surname>
<given-names><![CDATA[MAD]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[MAM]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Zambrano]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Zilberman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Múnera-Echeverri]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Paniagua]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía de práctica clínica de la Sociedad Interamericana de Cardiología sobre prevención primaria de enfermedad cardiovascular en la mujer]]></article-title>
<source><![CDATA[Arch Cardiol Mex]]></source>
<year>2022</year>
<volume>92</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>1-68</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vogel]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Acevedo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Appelman]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Merz]]></surname>
<given-names><![CDATA[CNB]]></given-names>
</name>
<name>
<surname><![CDATA[Chieffo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Figtree]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2021</year>
<volume>397</volume>
<numero>10292</numero>
<issue>10292</issue>
<page-range>2385-438</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="">
<collab>The American College of Cardiology</collab>
<source><![CDATA[The ASCVD Risk Estimator]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hajifathalian]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ueda]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Woodward]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmadvand]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar-Salinas]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys]]></article-title>
<source><![CDATA[Lancet Diabetes Endocrinol]]></source>
<year>2015</year>
<volume>3</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>339-55</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bakris]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Parati]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ACC/AHA versus ESC/ESH on hypertension guidelines]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2019</year>
<volume>73</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>3018-26</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosas-Peralta]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Palomo-Piñón]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Borrayo-Sánchez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Madrid-Miller]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Almeida-Gutiérrez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Galván-Oseguera]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consenso de hipertensión arterial sistémica en México]]></article-title>
<source><![CDATA[Rev Med Inst Mex Seguro Soc]]></source>
<year>2016</year>
<volume>54</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>6-51</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yusuf]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hawken]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ounpuu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dans]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Avezum]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lanas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2004</year>
<volume>364</volume>
<numero>9438</numero>
<issue>9438</issue>
<page-range>937-52</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barquera]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Barrera]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Trejo-Valdivia]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Shamah]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Campos-Nonato]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera-Dommarco]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesity in Mexico, prevalence and trends in adults. ENSANUT 2018-19]]></article-title>
<source><![CDATA[Salud Pública Mex]]></source>
<year>2020</year>
<volume>62</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>682-92</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<source><![CDATA[Estudio Nacional de Salud y Envejecimiento en México (ENASEM)]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lara-Esqueda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Meaney]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ceballos-Reyes]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Asbun-Bojalil]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ocharán-Hernández]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo cardiovascular en población femenina urbana de México. El estudio FRIMEX IIa]]></article-title>
<source><![CDATA[Rev Mex Cardiol]]></source>
<year>2007</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>24-34</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benschop]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Duvekot]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Roeters van Lennep]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy]]></article-title>
<source><![CDATA[Heart]]></source>
<year>2019</year>
<volume>105</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>1273-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
